Corporate investor

Merck & Co., Inc.

Compiled from public sources

Merck & Co., Inc. is a global healthcare company based in Kenilworth, New Jersey, USA, with a long-standing history in pharmaceutical innovation. Founded in 1891, Merck focuses on developing and delivering prescription medicines, vaccines, biologic therapies, and animal health products. The company is deeply committed to improving global health outcomes, with a significant emphasis on addressing infectious diseases, cancer, and other critical health challenges. Merck invests both directly through its own venture funds, such as the Merck Global Health Innovation Fund (GHIF), and as a Limited Partner (LP) in external funds, such as the Transform Health Fund. Through these investments, Merck seeks to support early-stage companies and healthcare solutions that align with its mission of improving lives through innovative healthcare.